环境感应芳香烃受体抑制动脉粥样硬化病变中调节型平滑肌细胞的软骨生成命运
该研究探讨芳香烃受体(AHR)是否通过调控平滑肌细胞(SMC)表型调节影响动脉粥样硬化。研究结合人冠状动脉SMC的基因组学与功能实验,以及SMC特异性Ahr敲除小鼠模型,发现AHR通路在病变帽区的调节型SMC中活跃,其缺失增加软骨样细胞(chondromyocyte)转化并削弱病变帽完整性,提示AHR可能具有保护作用。
要点
- AHR通路在动脉粥样硬化病变帽的调节型SMC中活跃,促进帽完整性维持。
- SMC特异性Ahr敲除增加Col2a1和Alpl阳性软骨样细胞,导致病变增大和帽内SMC减少。
- 人类冠状动脉新内膜中也存在软骨样细胞,提示AHR的保护作用可能具有临床相关性。
核心结论
- AHR通过抑制SMC向软骨样细胞转化,促进病变帽完整性维持,可能对动脉粥样硬化具有保护作用。
研究设计与样本
- 研究结合人冠状动脉SMC的RNA测序、ChIP测序、ATAC测序及体外功能实验,与SMC特异性谱系追踪Ahr敲除小鼠模型的单细胞RNA测序、组织学和RNAscope分析。
主要发现
- 人冠状动脉SMC基因组与功能实验显示AHR调节SMC表型并抑制这些细胞的骨化。
- 小鼠主动脉窦谱系与活性追踪显示Ahr通路在病变帽的调节型SMC中活跃。
- SMC特异性Ahr敲除小鼠单细胞RNA测序显示表达Col2a1和Alpl的调节型SMC比例显著增加,定位于病变新内膜。
- 组织学分析显示Ahr敲除较野生型小鼠病变更大、谱系追踪SMC参与病变增加、病变帽内谱系追踪SMC减少、病变碱性磷酸酶活性增加。
- 人类冠状动脉新内膜中也鉴定出软骨样细胞。
临床怎么用
- AHR通路可能作为维持动脉粥样硬化病变帽稳定性的潜在干预靶点,但需进一步临床验证。
局限性
- 结论基于小鼠模型和人类细胞实验,AHR在人体动脉粥样硬化中的保护作用需临床研究证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Smooth muscle cells (SMC) play a critical role in atherosclerosis. The Aryl hydrocarbon receptor (AHR) is an environment-sensing transcription factor that contributes to vascular development, and has been implicated in coronary artery disease risk. We hypothesized that AHR can affect atherosclerosis by regulating phenotypic modulation of SMC. METHODS: We combined RNA-sequencing, chromatin immunoprecipitation followed by sequencing, assay for transposase-accessible chromatin using sequencing, and in vitro assays in human coronary artery SMCs, with single-cell RNA-sequencing, histology, and RNAscope in an SMC-specific lineage-tracing Ahr knockout mouse model of atherosclerosis to better understand the role of AHR in vascular disease. RESULTS: Genomic studies coupled with functional assays in cultured human coronary artery SMCs revealed that AHR modulates the human coronary artery SMC phenotype and suppresses ossification in these cells. Lineage-tracing and activity-tracing studies in the mouse aortic sinus showed that the Ahr pathway is active in modulated SMCs in the atherosclerotic lesion cap. Furthermore, single-cell RNA-sequencing studies of the SMC-specific Ahr knockout mice showed a significant increase in the proportion of modulated SMCs expressing chondrocyte markers such as Col2a1 and Alpl, which localized to the lesion neointima. These cells, which we term "chondromyocytes," were also identified in the neointima of human coronary arteries. In histological analyses, these changes manifested as larger lesion size, increased lineage-traced SMC participation in the lesion, decreased lineage-traced SMCs in the lesion cap, and increased alkaline phosphatase activity in lesions in the Ahr knockout in comparison with wild-type mice. We propose that AHR is likely protective based on these data and inference from human genetic analyses. CONCLUSIONS: Overall, we conclude that AHR promotes the maintenance of lesion cap integrity and diminishes the disease-related SMC-to-chondromyocyte transition in atherosclerotic tissues.
引用
- Kim JB, Zhao Q, Nguyen T, et al. Environment-Sensing Aryl Hydrocarbon Receptor Inhibits the Chondrogenic Fate of Modulated Smooth Muscle Cells in Atherosclerotic Lesions. Circulation. 2020. PMID: 32441123. doi:10.1161/CIRCULATIONAHA.120.045981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。